Xsolla and Global Game Jam Announce a New Webinar to Help Indie Developers Grow Player Bases and Generate First Sales for Their Games
Xsolla, a leading global video game commerce company, announces a new collaboration with Global Game Jam (GGJ) to host a live webinar for indie developers titled “From Zero to 1K: Growing Your Player Base and Making Your First $$.” The session will take place on Tuesday, September 9, 2025, at 10:00 AM PT, offering actionable strategies to help developers attract their first audience and begin generating sustainable revenue.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250908673871/en/
(Graphic: Xsolla)
Bringing together game industry leaders and experienced developers, the event will provide beginner-friendly insights on how to make a game appealing to players while establishing effective monetization tactics. Attendees will learn how to avoid common early mistakes and gain practical tools for setting their projects up for long-term success.
Key takeaways from the webinar include:
- Proven ways to start generating revenue from a game
- Strategies to attract and grow the first 1,000 players and beyond
- Tips for building momentum and preparing for long-term success in game development
Featured speakers include Berkley Egenes, Chief Growth & Marketing Officer at Xsolla; A.J. Fulco, CEO of Tastie Games; and other special guests from the indie development community. Jess Rowley, Events & Program Manager at Global Game Jam, will moderate the discussion.
“Indie developers face unique challenges in building their first communities and generating revenue without the support of large budgets or teams,” said Chris Hewish, Chief Strategy & Communications Officer at Xsolla. “This collaboration with Global Game Jam allows us to provide practical, proven guidance from industry voices who have successfully navigated these same challenges.”
Global Game Jam will host the webinar on StreamYard with registration managed through Luma. Promotion will be shared across both GGJ and Xsolla channels, reaching game developers worldwide.
Registration is now open for free for developers seeking practical, actionable strategies to take their projects from zero to 1,000 players and beyond. To sign up, visit: xsolla.events/ggj
About Xsolla
Xsolla is a global commerce company with robust tools and services to help developers solve the inherent challenges of the video game industry. From indie to AAA, companies partner with Xsolla to help them fund, distribute, market, and monetize their games. Grounded in the belief in the future of video games, Xsolla is resolute in the mission to bring opportunities together, and continually make new resources available to creators. Headquartered and incorporated in Los Angeles, California, Xsolla operates as the merchant of record and has helped over 1,500+ game developers to reach more players and grow their businesses around the world. With more paths to profits and ways to win, developers have all the things needed to enjoy the game.
For more information, visit xsolla.com
About Global Game Jam
The Global Game Jam (GGJ) is the world’s largest game creation event, bringing together developers, artists, and creators of all experience levels to innovate, experiment, and create games within a 48-hour period. GGJ fosters creativity, collaboration, and learning within a global community of game makers.
For more information, visit: globalgamejam.org
View source version on businesswire.com: https://www.businesswire.com/news/home/20250908673871/en/
Contacts
Media Contact
Derrick Stembridge
Vice President of Global Public Relations, Xsolla
d.stembridge@xsolla.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Owlet Makes Premium Monitoring Possible for Every Family With New Dream Sight™ Video Monitor9.9.2025 14:45:00 EEST | Press release
Owlet, Inc. (NYSE: OWLT) (the “Company” or “Owlet”), the pioneer of smart infant monitoring, announces the launch of its new HD video baby monitor, Dream Sight™, and next-generation Dream Duo™. These products represent an important step for Owlet in the category, featuring advanced technology designed to provide clarity, connection, and peace of mind from day one. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909618049/en/ Owlet's Dream Sight 2K HD Video Monitor. “Parents are clear about what they need in a baby monitor – more advanced features, greater reliability, deeper security, and a price point that makes sense,” said Kurt Workman, Owlet’s Chief Executive Officer and Co-Founder. “Dream Sight is a direct response to that feedback from our customers. When paired with our medically-certified Dream Sock®, it creates a connected monitoring experience that gives caregivers the confidence and peace of mind they need.” Int
France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer9.9.2025 14:43:00 EEST | Press release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory microsatellite‑stable (MSS) metastatic colorectal cancer (mCRC) under France’s compassionate access (Accès compassionnel, or AAC) framework. The French National Agency of Medicines and Health Products Safety’s (ANSM) listings for botensilimab and balstilimab are live and detail eligibility (including MSS and no active liver metastases) and dosing. BOT/BAL remains investigational and is not approved for commercial marketing in France or elsewhere. How AAC reimbursement works Once the ANSM authorizes AAC, hospital use is covered 100% by Assurance Maladie. Hospitals are reimbursed at the invoiced purchase price (TTC), outside the Diagnosis-related Group (DRG), referred to in France as “en sus du GHS”. During AAC the manufacturer either provides the medicine free of charge or invoices an “indem
Promega and Watchmaker Genomics Announce Strategic Partnership to Advance Molecular Analysis with Next-Generation Reverse Transcriptase9.9.2025 14:11:00 EEST | Press release
Promega Corporation has entered a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase. Designed for enhanced accuracy and sensitivity in RNA analysis, the enzyme will enhance Promega capabilities to manufacture and deliver both catalog and customized solutions for clinical, applied and pharmaceutical molecular applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250908209296/en/ “Watchmaker’s enzyme offers a combination of attributes that establish a new benchmark for reverse transcriptase performance,” says Sara Mann, VP of Commercial Excellence at Promega. “By incorporating it into our portfolio, we are giving customers a powerful tool for improved accuracy and enhanced sensitivity of RNA-based assays.” This partnership marks the beginning of an expanded collaboration between Watchmaker Genomics and Promega, with both companies committed to developing next-generation e
Kinaxis Powers Shimadzu’s Supply Chain Advancement for the Modern Manufacturing Era9.9.2025 14:00:00 EEST | Press release
Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that Shimadzu Corporation, a top manufacturer of high-technology precision instruments, has selected the Kinaxis Maestro® platform to advance its supply chain strategy and outmaneuver global trade volatility. Shimadzu is turning to Maestro to simulate real-world trade scenarios, align cross-functional teams and proactively act before disruption hits. Shimadzu makes precision equipment for high-stakes industries from pharmaceuticals to aerospace where speed and foresight are critical. As they expand globally, Shimadzu needed a supply chain technology platform that could process complex data, provide instant optionality and protect profits as it navigates a dynamic global tariff and trade environment. “We have built our reputation on precision, innovation and excellence for our partners,” said Akira Okubo, corporate officer, general manager, DX・IT strategy management department at Shimadzu Corpo
IFF launches interactive platform to inspire adult beverage innovation9.9.2025 14:00:00 EEST | Press release
IFF (NYSE: IFF), a global leader in food, beverage, health and wellness, has unveiled SipScape, a new platform designed to inspire innovation across the rapidly evolving adult beverage landscape. It offers actionable insights and trends, including product design, flavor modulation and sweetness reduction in no-and low-alcohol beverages. The platform also highlights IFF’s expertise in incorporating botanicals, natural colors and other functional additions based on current trends and market demands. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909611189/en/ Photo credit: IFF “Understanding how and why people drink today is essential to staying ahead,” said Fernanda De Paula, vice president of global beverages category for IFF Taste. “Consumers are looking for more than a buzz, and drinks are no longer defined solely by their alcohol content. The most successful new products are those that reflect people’s values, fulfill
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom